TY - JOUR
T1 - Identifying important breast cancer control strategies in Asia, Latin America and the Middle East/North Africa
AU - Bridges, John Fp
AU - Anderson, Benjamin O.
AU - Buzaid, Antonio C.
AU - Jazieh, Abdul R.
AU - Niessen, Louis W.
AU - Blauvelt, Barri M.
AU - Buchanan, David R.
N1 - Funding Information:
This study was supported, in part, by funding from GlaxoSmithKline (GSK), International Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank Joseph Mole of Wolters Kluwer Health for his help editing an earlier version of this manuscript, and Lindsay Kennedy Brown, Sarah Searle and Samir Podder for their research assistance. They also would like to thank the following advisors, including Dr. Martine Piccart of the Jules Bordet Institute (Belgium); Dr. Alan Coates of University of Sydney (Australia); Lillie Shockney, Avon Breast Center, Johns Hopkins University Hospital (USA); and Dr. Eric Winer, Dana Farber Cancer Institute, Harvard University/Partners Health Care (USA). They also would like to thank respondents who became advisors, including Dr. John Forbes, Newcastle University and the Australia New Zealand Breast Cancer Research Group; Dr. Helen Zorbas of the Breast and Ovarian Cancer Centre (Australia); Dr. Ian Olver, Cancer Council (Australia), Dr. Carlos Barrios, Pontificia Universidade Católica Rio Grand do Sul and Cancer Institute, Hospital Mãe de Deus (Brazil); Dr. John Mackey, Cross Cancer Institutes, University of Alberta (Canada); Dr. Maureen Trudeau, Odette Cancer Center, Sunnybrook Hospital (Canada); Dr. Jose M Reyes Vidal, Cancer Institute, Clinica Las Condes, Universidad de Chile and Corporacíon Nacíonal del Cancer (Chile); BH Xu, PhD, Cancer Hospital and Institute, Chinese Academy of Medical Sciences, Peking Union Medical College and National Drug Evaluation Center (China); Dr. Omalkhair Abdullah Abulkhair, National Guard Hospital (Kingdom of Saudi Arabia); Dr. Suresh Advani, Jasiok Hospital and Research Centre (India); Dr. Sung Bae Kim, Samsung Comprehensive Cancer Center (S Korea); Dr. C S Huang, National Taiwan University Hospital (Taiwan); and Dr. Pinar Saip (Turkey). Finally, they also would like to thank GSK Oncology for their financial support of the study, as well as all other respondents who participated in the study for the generosity of their time and candor, and without compensation.
PY - 2011
Y1 - 2011
N2 - Background: Breast cancer is the most frequent cause of cancer death in women worldwide, but global disparities in breast cancer control persist, due to a lack of a comprehensive breast cancer control strategy in many countries. Objectives. To identify and compare the need for breast cancer control strategies in Asia, Latin America and the Middle East/North Africa and to develop a common framework to guide the development of national breast cancer control strategies. Methods. Data were derived from open-ended, semi-structured interviews conducted in 2007 with 221 clinicians, policy makers, and patient advocates; stratified across Asia (n = 97), Latin America (n = 46), the Middle East/North Africa (ME/NA) (n = 39) and Australia and Canada (n = 39). Respondents were identified using purposive and snowballing sampling. Interpretation of the data utilized interpretive phenomenological analysis where transcripts and field notes were coded and analyzed and common themes were identified. Analysis of regional variation was conducted based on the frequency of discussion and the writing of the manuscript followed the RATS guidelines. Results: Analysis revealed four major themes that form the foundation for developing national breast cancer control strategies: 1) building capacity; 2) developing evidence; 3) removing barriers; and 4) promoting advocacy - each specified across five sub-ordinate dimensions. The propensity to discuss most dimensions was similar across regions, but managing advocacy was discussed more frequently (p = 0.004) and organized advocacy was discussed less frequently (p < 0.001) in Australia and Canada. Conclusions: This unique research identified common themes for the development of breast cancer control strategies, grounded in the experience of local practitioners, policy makers and advocacy leaders across diverse regions. Future research should be aimed at gathering a wider array of experiences, including those of patients.
AB - Background: Breast cancer is the most frequent cause of cancer death in women worldwide, but global disparities in breast cancer control persist, due to a lack of a comprehensive breast cancer control strategy in many countries. Objectives. To identify and compare the need for breast cancer control strategies in Asia, Latin America and the Middle East/North Africa and to develop a common framework to guide the development of national breast cancer control strategies. Methods. Data were derived from open-ended, semi-structured interviews conducted in 2007 with 221 clinicians, policy makers, and patient advocates; stratified across Asia (n = 97), Latin America (n = 46), the Middle East/North Africa (ME/NA) (n = 39) and Australia and Canada (n = 39). Respondents were identified using purposive and snowballing sampling. Interpretation of the data utilized interpretive phenomenological analysis where transcripts and field notes were coded and analyzed and common themes were identified. Analysis of regional variation was conducted based on the frequency of discussion and the writing of the manuscript followed the RATS guidelines. Results: Analysis revealed four major themes that form the foundation for developing national breast cancer control strategies: 1) building capacity; 2) developing evidence; 3) removing barriers; and 4) promoting advocacy - each specified across five sub-ordinate dimensions. The propensity to discuss most dimensions was similar across regions, but managing advocacy was discussed more frequently (p = 0.004) and organized advocacy was discussed less frequently (p < 0.001) in Australia and Canada. Conclusions: This unique research identified common themes for the development of breast cancer control strategies, grounded in the experience of local practitioners, policy makers and advocacy leaders across diverse regions. Future research should be aimed at gathering a wider array of experiences, including those of patients.
UR - http://www.scopus.com/inward/record.url?scp=80053175231&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053175231&partnerID=8YFLogxK
U2 - 10.1186/1472-6963-11-227
DO - 10.1186/1472-6963-11-227
M3 - Article
C2 - 21933435
AN - SCOPUS:80053175231
SN - 1472-6963
VL - 11
JO - BMC health services research
JF - BMC health services research
M1 - 227
ER -